Clinical Trial

Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations

Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to verify the form, fit and function of the Philips FAST technology with Masimo neonatal, infant and pediatric sensors for SpO2 monitoring in the respective indicated populations. The study design uses convenience sample data collection from neonatal, infant, and pediatric sensors within their respective indicated patient populations that have a range of different skin pigmentations, simultaneously with an FDA cleared pulse oximeter as a comparator.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06-05 -> 2026-12-31 2026-07-14
minor Completion pushed: 2026-06-05 -> 2026-12-31 2026-07-14
Trial Details
NCT Number NCT07223177
Lead Sponsor Masimo Corporation
Conditions SpO2
Enrollment 100 participants
Start Date 2025-12-17
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-13